Navigation Links
GeoVax Labs Inc. Announces Results of 2010 Annual Stockholders Meeting
Date:8/27/2010

ATLANTA, Aug. 27 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, today announced the results of its Annual Shareholders Meeting, held on August 24, 2010.

During the meeting, shareholders re-elected seven nominees for directors of the company to serve until the 2011 Annual Meeting of Shareholders and until their successors are duly elected or appointed and qualified. They are:

  • Donald G. Hildebrand, Chairman of the Board of Directors
  • Robert T. McNally, Ph.D., President and CEO
  • Harriet L. Robinson, Ph.D., Chief Scientific Officer
  • Steven S. Antebi, Independent Director
  • David A. Dodd, Independent Director
  • Dean G. Kollintzas, Independent Director
  • John N. Spencer, Jr., CPA, Independent Director

  • Additionally, stockholders ratified the appointment of Porter Keadle Moore LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2010.

    Don Hildebrand, company co-founder and Chairman of the Board of Directors, provided opening remarks and conducted the formal business of the meeting.

    In addition to the business of the annual meeting, Robert McNally, president and chief executive officer, provided an overview of the company's progress, highlighting GeoVax's performance since the last annual meeting held in June 2009. He discussed significant scientific outreach including conferences where GeoVax participated in presenting advances in vaccine development, and improvement in corporate communications through a new public and investor relations firm, IRG.  Dr. Harriet Robinson, company CSO, discussed clinical and research progress including the current status of the Phase 2a Preventative Vaccine Trial including the expansion from 225 to 300 part
    '/>"/>

    SOURCE GeoVax Labs, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
    2. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
    3. GeoVax Presents Data at AIDS Vaccine 2008 Conference
    4. GeoVaxs DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
    5. GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
    6. GeoVax to Present at the BIO CEO & Investor Conference 2009
    7. GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference
    8. GeoVax Update Provided at the BIO CEO & Investor Conference 2009
    9. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
    10. GeoVax Labs, Inc. Announces First Quarter Financial Results
    11. GeoVax to Exhibit at the 2009 BIO International Convention
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... BOTHELL, Wash. , Dec. 24, 2014   BioLife Solutions ... manufacturer and marketer of proprietary clinical grade hypothermic storage ... thermal shipping products for cells and tissues  ("BioLife" or ... Annual Meeting of Stockholders on May 4, 2015 (the "Annual ...
    (Date:12/24/2014)... Earlier this year in a June 24 ... Adult Stem Cell Technology Center, LLC ( ASCTC ) focused ... of adult tissue stem cells. His title “Asymmetric Self-Renewal ... the Future,” embodied the essence of his message to congress ...
    (Date:12/24/2014)... 23, 2014 According to Ross Selinger, President ... of ITRA Global, the national office market continues to be ... This is evidenced by the third quarter’s surprising 3.9% GDP, ... Low energy costs have held inflation down and the Fed ...
    (Date:12/24/2014)... The report expects global cell isolation and expansion market to ... analyzed data about the vital drivers, restraints, trends, opportunities, strategies ... @ http://bit.ly/1yUxy0T , According to the report, the ... an impressive CAGR during near future. It expects this growth ...
    Breaking Biology Technology:BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3
    ... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical ... results for the third quarter ended September 30, 2009. ... of this year, the FDA,s Arthritis Advisory Committee unanimously ... XIAFLEX(TM) for the treatment of Dupuytren,s disease, and we ...
    ... 5 Wound Management Technologies, Inc., (WNDM), announced today that ... all healthcare-related assets of Virtual Health Technologies, Inc. (OTC Bulletin ... $1,000,000 in cash and debt, 4,000,000 shares of WNDM and ... Veriscrip technology being acquired from VHGI. WNDM closed ...
    ... FREMONT, Calif., Nov. 5 WaferGen Biosystems, Inc. ... state-of-the-art genetic analysis systems, today announced that Christopher ... Board. His career has been focused on ... detection and other applications, and on the development ...
    Cached Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
    (Date:12/17/2014)... , Dec. 16, 2014  Automation is fundamentally transforming ... than at international borders. Over the past decade, ePassports, ... travelers to self process through border control via eGates ... number of airports, seaports, and land borders across the ...
    (Date:12/11/2014)... Dec. 10, 2014  That blood pressure plays a role in ... – the medical term for high blood pressure – was ... the inflatable cuff that,s used in measuring blood pressure was ... nothing new about hypertension, its triggers and its effects. In ...
    (Date:12/10/2014)... 9, 2014  Wake Forest Baptist Medical Center today announced plans ... Medicine. Funding for this $50 million capital project is part ... next summer. The medical education building will ... Company complex, adjacent to 525@vine in Wake Forest Innovation Quarter. ...
    Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
    ... of DNA may keep viral genes tightly wound within a ... of its structure has revealed. Using electron microscopy and ... produced the most detailed image yet of the protein envelope ... they report this week in the journal Structure . ...
    ... Smithsonian,s National Zoo have performed the first successful ... ferus przewalskii ; E. caballus przewalskii ... horse species native to China and Mongolia that ... Currently, there are approximately 1500 of these animals ...
    ... June 16 Authernative, Inc., a,leading developer ... announced today that it has been awarded ... contract, number,GS-35F-0440U. The contract enables Authernative to ... government agencies., The GSA Schedule contract, ...
    Cached Biology News:Scientists discover DNA knot keeps viral genes tightly corked inside shell 2First successful reverse vasectomy on endangered species performed at the National Zoo 2First successful reverse vasectomy on endangered species performed at the National Zoo 3Authernative Awarded GSA Schedule Contract 2Authernative Awarded GSA Schedule Contract 3
    BAFF-R (CT) BR3 Affinity Purified Polyclonal Antibody...
    Goat polyclonal to NIR1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: SWARGPPKFESVP, corresponding to C terminal amino acids 962-974 of NIR1. Entrez Gene ID: 83394 ...
    PMM2 Immunogen: PMM2 (NP_000294, 47 a.a. ~ 112 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
    HOXC11 Antibody...
    Biology Products: